Luca Rovati

Luca Rovati

Director Director DIN 02393560
DIN 02393560 First appointment Dec 2008 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2008
Shareholding value Locked Premium profile

About Luca Rovati

Data last updated:

Luca Rovati has 17 years in corporate governance. Formerly with 1 company, such as Madaus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 02393560
Primary Designation Director
First Appointment 22 Dec 2008
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Additional Director22 Dec 20081996Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Madaus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Luca Rovati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Luca Rovati

Luca Rovati has 17 years in corporate governance. Formerly with 1 company, such as Madaus Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Luca Rovati is associated with 0 companies as a director.

Luca Rovati has expertise in General Business.

Luca Rovati has 17 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available